8.2.2021 16:20:10 CET | Aqua Bio Technology ASA | Inside information
Aqua Bio Technology ASA: Hydrafacial announces partnership with Restorsea and launches new Restorsea™ Lip Fix Kit
Reference is made to the commercial update on November 26, 2020, where Aqua Bio Technology ASA (ABT) informed that Restorsea recently had entered into two license agreements with two partners in addition to the license agreement with NASDAQ-listed Conversion Labs.
Today HydraFacial officially announced its partnership with Restorsea and launched its new Restorsea™ Lip Fix Kit which is based on ABT’s hatching fluid ingredient (Aquabeautine XL). The kit includes the Restorsea™ Lip Serum, to be administered during the lip treatment, and the Lip Elixir gloss as a hydrator and natural exfoliator to be applied post-treatment
HydraFacial informs that HydraFacial® and Perk™ products are available in over 87 countries with over 15,000 delivery systems globally, performing millions of treatments each year. For further information on the partnership between HydraFacial and Restorsea, the new Restorsea™ Lip Fix Kit, and the HydraFacial brand, please see https://www.prnewswire.com/news-releases/the-hydrafacial-company-launches-new-lip-fix-kit-with-restorsea-301223291.html and visit LinkedIn, Facebook, Instagram, or at HydraFacial.com.
The positive trend from Restorsea’s commercialization of ABT’s proprietary technology increases the likelihood that ABT will receive additional renewal payments and increased revenue from the sale of ingredients and royalties from Restorsea and its licensees.
For further information, please contact Espen Kvale, CEO, telephone +47 916 28 092
Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT’s cosmetics ingredients are effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. ABT’s focus on commercialization and development of natural ingredients and natural skin care products has been, and will continue to be, an important part of the company’s strategy going forward. Aqua Bio Technology is listed on Euronext Expand.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Disclaimer
This information is subject of the disclosure requirements pursuant to section of 5-12 of the Norwegian Securities Trading Act.
Contacts
Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no
About Aqua Bio Technology ASA
Aqua Bio Technology (ABT) is developing and commercializing sustainablebiotechnology for use in skin care products. ABT’s cosmetics ingredients arehighly effective and they provide the cosmetics industry with naturalalternatives to traditional ingredients. ABT is also marketing and distributingnatural skin care products developed by partners towards consumers andprofessional users. Aqua Bio Technology is listed on the Axess market of theOslo Stock Exchange.
Attachments
Download announcement as PDF.pdf
